Comment and response to: dapagliflozin - do we need it registered for type 2 diabetes?
Publication/Presentation Date
12-1-2014
Volume
15
Issue
18
First Page
2751
Last Page
2752
ISSN
1744-7666
Published In/Presented At
Jabbour S. (2014). Comment and response to: dapagliflozin - do we need it registered for type 2 diabetes?. Expert opinion on pharmacotherapy, 15(18), 2751–2752. https://doi.org/10.1517/14656566.2014.974897
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
25346092
Department(s)
Administration and Leadership
Document Type
Article
COinS